Articles related to Medical Genetics

In this feature from the British Medical Journal (BMJ), associate editor Peter Doshi explores the emerging research on immunological responses to COVID-19. Is it true that the human population had no pre-existing immunity to SARS-CoV-2? The article attempts to answer this question with a deeper discussion around herd immunity, T cells, antibodies, and more.

Presented at the ASCO20 Virtual Scientific Program, data from the 1,459 patients who were African American, Hispanic, Native American, Pacific Islander, or Asian highlighted the need for increased surveillance for cutaneous toxicity in patients with darker pigmented skin. Immune-related cutaneous adverse events (irCAEs) were assessed by the Common Terminology Criteria for Adverse Events (CTCAE) v5.0.

The survey demonstrates the rapid adoption of telemedicine, with 48% of physicians respondents reporting that they are now treating patients through telemedicine, but the pandemic is also creating significant disruption as some physicians are furloughed and others consider practice changes.

Thanks to the Internet, more consumers than ever before are exposed to misleading, fraudulent medical hoaxes. These are five of the major culprits out there. Combat the misinformation for your patients and replace it with trustworthy, evidence-based research.

Published on the AUA website and developed by a panel of experts from these three groups as well as representation from the American Society of Clinical Oncology (ASCO) and a patient advocate, 38 recommendations are listed across the care continuum of advanced disease.

This JAMA “Viewpoint” describes how to interpret two types of diagnostic tests commonly in use for SARS-CoV-2 infections—reverse transcriptase–polymerase chain reaction (RT-PCR) and IgM and IgG enzyme-linked immunosorbent assay (ELISA)—and how the results may vary over time.